= Emerging. More than 5 years before clinical availability.
= Expected to be clinically available in 1 to 4 years.
= Clinically available now.

No entry found.


Financial Disclosure

DescriptionY/NSource
GrantsyesGlysign project funding from the European Union’s Horizon 2020
SalaryyesGenos d.o.o company based on Glysign project funding from the European Union’s Horizon 2020
Board Memberno
Stockno
ExpensesyesGenos d.o.o company based on Glysign project funding from the European Union’s Horizon 2020
IP Royaltyno

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no